المؤلفون: Matthias Egger, Stephan Probst, Jörg Trojan, Alexander Reichart, Dirk M Behringer, Salah-Eddin Al-Batran, Volker Rethwisch, Michael Pohl, Gerald Illerhaus, Jan Stoehlmacher, Jörg Weniger, Daniel Pink, Wael Hozaeel, Rolf Mahlberg, Georg Martin Haag, Severin Daum, Carmen Löhr, Wolff Schmiegel, Michael Heike, G. Schuch, Timo Gaiser, Flot Aio Investigators, Thorsten Oliver Goetze, Helga Bernhard, Sebastian Belle, Nils Homann, Johannes Meiler, Hans-Georg Kopp, Nicole Prasnikar, Christian Teschendorf, Andreas Block, Michael Schenk, Volker Heinemann, Markus Moehler, Stefan Kasper, Claudia Pauligk, Kim Barbara Luley, Ralf Hofheinz, Harald Schmalenberg, Michael Kneba, Frank Kullmann, Wolf O. Bechstein, Jörg T. Hartmann, Uwe M. Martens, Martin Schuler, U. Lindig, Fuat Oduncu, Peter C. Thuss-Patience, Thomas Kraus, Gunnar Folprecht, Frank Mayer, Michael Koenigsmann, Elke Jäger, Wolfgang Fischbach, Stefan Mönig, Ludwig Fischer von Weikersthal, Martina Güntner, Karsten Schulmann

المصدر: The Lancet. 393:1948-1957

مصطلحات موضوعية: medicine.medical_specialty, education.field_of_study, Chemotherapy, business.industry, medicine.medical_treatment, Population, Medizin, General Medicine, Perioperative, 030204 cardiovascular system & hematology, Gastroenterology, Oxaliplatin, Capecitabine, 03 medical and health sciences, 0302 clinical medicine, Docetaxel, Fluorouracil, Internal medicine, Medicine, 030212 general & internal medicine, business, education, medicine.drug, Epirubicin

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bb9328f246b91519e1997e982c1bc7cTest
https://doi.org/10.1016/s0140-6736Test(18)32557-1

المؤلفون: Helmut Friess, Dirk Waldschmidt, Holger Schulz, Martin Fuchs, Eray Goekkurt, Thomas Geer, Volker Heinemann, Wolfgang Blau, Marcel Reiser, Metin Senkal, Uwe Pelzer, Ralf Jakobs, Michael Stahl, Matthias Egger, Swantje Held, Jens T. Siveke, Ralph Keller, Christina Große-Thie, Thomas J. Ettrich, Stefan Boeck, Hubert J. Stein, Ingo Hartlapp, Georg Maschmeyer, Peter Fix, Thomas Südhoff, U. Lindig, Elke Hennes, Marcus Bahra, Volker Kunzmann, Ingo Klein, Frank Kullmann, Gabriele Margareta Siegler, Christoph Kahl, Hana Algül, Christoph-Thomas Germer, Uwe M. Martens, Stefan Mahlmann

المساهمون: Stahl, Michael (Beitragende*r), Mahlmann, Stefan (Beitragende*r)

مصطلحات موضوعية: Male, FOLFIRINOX, Leucovorin, Medizin, Phases of clinical research, Deoxycytidine, Gastroenterology, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Aged, 80 and over, education.field_of_study, Induction Chemotherapy, Middle Aged, Neoadjuvant Therapy, Oxaliplatin, Treatment Outcome, 030220 oncology & carcinogenesis, Female, 030211 gastroenterology & hepatology, Fluorouracil, medicine.drug, Adult, medicine.medical_specialty, Adolescent, Paclitaxel, Population, Antineoplastic Agents, Adenocarcinoma, Irinotecan, Drug Administration Schedule, Young Adult, 03 medical and health sciences, Pancreatectomy, Albumins, Internal medicine, medicine, Humans, education, Aged, Neoplasm Staging, Hepatology, business.industry, Induction chemotherapy, medicine.disease, Gemcitabine, Pancreatic Neoplasms, business, Progressive disease, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1066cfe3208263c113f5fd0c464ccbd8Test
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85099144148Test

المؤلفون: Michael Fluck, Patrick Terheyden, Peter Mohr, Beate Conrad, Carmen Loquai, Bastian Schilling, Christine Windemuth-Kieselbach, Friedegund Meier, Christian Menzer, Felix Kieker, Silvia Körner, Jochen Utikal, Rudolf A. Herbst, Alexander Rösch, Thomas Eigentler, Carola Berking, Axel Hauschild, Jessica C. Hassel, Dirk Schadendorf, Edgar Dippel, Lisa Zimmer, Jürgen C. Becker, Uwe M. Martens, Rudolf Stadler, Leonora Schwarz, Elisabeth Livingstone, Sabine Sell, Sebastian Haferkamp, Ralf Gutzmer, Claus Garbe, Jan-Christoph Simon

المصدر: Lancet (London, England). 395(10236)

مصطلحات موضوعية: medicine.medical_specialty, Skin Neoplasms, Population, Medizin, Ipilimumab, 030204 cardiovascular system & hematology, Placebo, Drug Administration Schedule, 03 medical and health sciences, 0302 clinical medicine, Antineoplastic Agents, Immunological, Adjuvants, Immunologic, Double-Blind Method, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Clinical endpoint, Adjuvant therapy, Medicine, Humans, 030212 general & internal medicine, Progression-free survival, education, Melanoma, Aged, Neoplasm Staging, education.field_of_study, business.industry, General Medicine, Middle Aged, Interim analysis, Progression-Free Survival, Nivolumab, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0dd0e8a8f5cae4bc6aab1b99e6a7d3a0Test
https://pubmed.ncbi.nlm.nih.gov/32472086Test

المؤلفون: Hans-Heinrich Wolf, Manfred Binder, Gabriele Ihorst, Johannes Bloehdorn, Martina Deckert, Benjamin Kasenda, Anke Morgner, Johannes Atta, Ulrich Keller, Juergen Finke, Peter Hau, Kristina Fritsch, Alexander Röth, Carsten Hirt, Gerald Illerhaus, Norbert Frickhofen, Löw S, Jens Panse, Ralph Naumann, Heß G, Stephanie Sasse, Uwe M. Martens, Stefan W. Krause, Claudia Hader, Monika Lamprecht, Heidi Fricker, Elisabeth Schorb, Robert Möhle

المصدر: Leukemia
Leukemia : normal and malignant hemopoiesis 31(4), 846-852 (2017). doi:10.1038/leu.2016.334

مصطلحات موضوعية: Male, Cancer Research, medicine.medical_specialty, Lymphoma, Population, Medizin, Procarbazine, Gastroenterology, Central Nervous System Neoplasms, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Immunologic Factors, education, Aged, Neoplasm Staging, Proportional Hazards Models, Aged, 80 and over, education.field_of_study, Hematology, business.industry, Remission Induction, Primary central nervous system lymphoma, Lomustine, medicine.disease, Surgery, Tumor Burden, Methotrexate, Treatment Outcome, Oncology, 030220 oncology & carcinogenesis, Cytarabine, Quality of Life, Rituximab, Original Article, Female, business, 030215 immunology, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b788727f36c75ddb2bbdc7cd8e48373Test
http://europepmc.org/articles/PMC5383936Test

المؤلفون: Igor Wolfgang Blau, Katja Weisel, Jan Duerig, Mathias Haenel, Roland Fenk, Uta Bertsch, Christina Kunz, Stefanie Huhn, Marc S. Raab, Hartmut Goldschmidt, Uwe M. Martens, Ullrich Graeven, Manfred Hensel, Stefan Fronhoffs, Jens Hillengass, Mohammed Wattad, Hans Salwender, Markus Munder, Anna Jauch, Hans-Walter Lindemann, Timon Hansen, Dirk Hose, Christof Scheid, Axel Benner, Mindaugas Andrulis, Michael Hundemer, Andrea Seidel-Glaetzer

المساهمون: Hematology, Basic (bio-) Medical Sciences

المصدر: BMC Cancer
BMC Cancer, Vol 19, Iss 1, Pp 1-11 (2019)

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, medicine.medical_treatment, Medizin, Dexamethasone, Bortezomib, Study Protocol, 610 Medical sciences Medicine, 0302 clinical medicine, Autologous stem-cell transplantation, Multiple myeloma, Clinical endpoint, Lenalidomide/administration & dosage, Prospective Studies, Elotuzumab, Lenalidomide, Melphalan, hematology, Hematopoietic Stem Cell Transplantation, Induction Chemotherapy, Middle Aged, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, elotuzumab, Multiple Myeloma/therapy, Treatment Outcome, Research Design, 030220 oncology & carcinogenesis, Female, autologous stem cell transplant, Antibodies, Monoclonal, Humanized/administration & dosage, medicine.drug, Dexamethasone/administration & dosage, Adult, Melphalan/administration & dosage, medicine.medical_specialty, Antibodies, Monoclonal, Humanized, lcsh:RC254-282, Maintenance Chemotherapy, 03 medical and health sciences, Young Adult, Internal medicine, Genetics, medicine, Humans, Aged, Chemotherapy, business.industry, medicine.disease, Survival Analysis, Consolidation Chemotherapy, 030104 developmental biology, Quality of Life, Bortezomib/administration & dosage, business, high-dose chemotherapy

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18b58d1361d94b3c6f22e13502a6ffd2Test
http://europepmc.org/articles/PMC6537200Test

المؤلفون: Hana Alguel, Elke Hennes, Volker Kunzmann, Eray Goekkurt, Ralf Jakobs, Markus Kapp, Gabriele Margareta Siegler, Uwe Pelzer, Frank Kullmann, Ralph Keller, Uwe M. Martens, Dirk Waldschmidt, Jens T. Siveke, Stefan Boeck, Christoph-Thomas Germer, Peter Ferenczy

مصطلحات موضوعية: Oncology, Cancer Research, Chemotherapy, medicine.medical_specialty, Pancreatic ductal adenocarcinoma, business.industry, FOLFIRINOX, medicine.medical_treatment, Medizin, Induction chemotherapy, Gemcitabine, Locally advanced pancreatic cancer, 03 medical and health sciences, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, Interim, medicine, 030211 gastroenterology & hepatology, business, Nab-paclitaxel, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a985c17b71c6b887f260d57eb51fa103Test

المؤلفون: Jörg Trojan, Matthias Egger, Michael Pohl, Mark Sievert, Timo Gaiser, Dirk Behringer, Elke Jäger, Salah-Eddin Al-Batran, Alfred Königsrainer, Uwe M. Martens, Karel Caca, Michael Heike, Katja Zirlik, Wolfgang Fischbach, Andrea Tannapfel, Gerald Illerhaus, Wolf O. Bechstein, Ulrich Ronellenfitsch, Alexander Reichart, Stephan Probst, Georg Martin Haag, Kim Barbara Luley, Nils Homann, Andreas Block, Sylvie Lorenzen, Peter Schirmacher, Stefan Mönig, Thorsten Oliver Goetze, Martin Schuler, Michael Koenigsmann, Harald Schmalenberg, Wael Hozaeel, Wolff Schmiegel, Hans-Georg Kopp, Ralf Hofheinz, Michael R. Clemens, Claudia Pauligk, Rolf Mahlberg, Johannes Meiler, Nicole Prasnikar

المصدر: Lancet. Oncology, Vol. 17, No 12 (2016) pp. 1697-1708

مصطلحات موضوعية: Male, Esophageal Neoplasms, Leucovorin, Medizin, Docetaxel, Adenocarcinoma / pathology, Gastroenterology, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Antineoplastic Combined Chemotherapy Protocols / adverse effects, Esophageal Neoplasms / pathology, Esophageal Neoplasms / surgery, education.field_of_study, Esophageal Neoplasms / drug therapy, ddc:617, Adenocarcinoma / surgery, Middle Aged, Neoadjuvant Therapy, Oncology, Fluorouracil, 030220 oncology & carcinogenesis, Adenocarcinoma / drug therapy, 030211 gastroenterology & hepatology, Taxoids, Female, Esophagogastric Junction, Cisplatin / administration & dosage, medicine.drug, Epirubicin, Adult, medicine.medical_specialty, Population, Context (language use), Stomach Neoplasms / drug therapy, Adenocarcinoma, Capecitabine, 03 medical and health sciences, Stomach Neoplasms, Internal medicine, Antineoplastic Combined Chemotherapy Protocols / therapeutic use, medicine, Humans, education, Aged, Taxoids / administration & dosage, Leucovorin / administration & dosage, business.industry, Interim analysis, Surgery, Oxaliplatin, Cisplatin, business, Stomach Neoplasms / pathology, Epirubicin / administration & dosage, Stomach Neoplasms / surgery

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::782f264dc0eab2317cc3a34935c64c8cTest
https://archive-ouverte.unige.ch/unige:158705Test